Edwards Lifesciences Corporation Stock News

Oppenheimer analyst Suraj Kalia assigned a Buy rating to Edwards Lifesciences (EW – Research Report) yesterday and set a price

Abbott Laboratories undefined and Edwards Lifesciences Corp. undefined said late Monday they settled a patent dispute with each other over certain heart...

Abbott Laboratories and Edwards Lifesciences Corp. said late Monday they settled a patent dispute with each other over certain heart valve repair products. The two medical device makers have been em

Edwards Lifesciences Corporation (NYSE: EW), the global leader in patient-focused innovations for structural heart disease and critical care monitoring, today announced that it has reached an agreemen

Octapharma announced today that new research findings from its haematology portfolio will be presented at the upcoming International Society on Thromb

Edwards Lifesciences Corp (NYSE:EW) CEO Michael A. Mussallem sold 68,550 shares of the company’s stock in a transaction dated Thursday, July 9th. The shares were sold at an average price of $68.22,

Geoff Keighley followed the creation of Half-Life: Alyx over four years and he published a peek inside Valve as a Steam app on Thursday.

Edwards Lifesciences Corporation (NYSE: EW), the global leader in patient-focused innovations for structural heart disease and critical care monitoring, plans to announce its operating results for the

We know that hedge funds generate strong, risk-adjusted returns over the long run, which is why imitating the picks that they are collectively bullish on can be a profitable strategy for retail invest

Investors continue to be upbeat about Edwards Lifesciences (EW) owing to its strong segmental growth and robust product demand.

Protaryx Medical, a Baltimore, Maryland-based company committed to improving access to the left atrium for transcatheter cardiac procedures, raised $8.3m in funding

Wall Street analysts expect Edwards Lifesciences Corp (NYSE:EW) to report earnings per share (EPS) of $0.41 for the current fiscal quarter, according to Zacks. Nine analysts have issued estimates for

Dota 2 developer Valve has announced that the sale of the battle pass level bundle will continue until July 2 after the item caused the prize pool for The International 10 to grow by $8 million in und

Research initiated by RCSI and Beaumont Hospital to assess impact of treatment on critically ill